Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients.
Cassidy J, Twelves C, Cameron D, Steward W, O'Byrne K, Jodrell D, Banken L, Goggin T, Jones D, Roos B, Bush E, Weidekamm E, Reigner B. Cassidy J, et al. Among authors: roos b. Cancer Chemother Pharmacol. 1999;44(6):453-60. doi: 10.1007/s002800051118. Cancer Chemother Pharmacol. 1999. PMID: 10550565 Clinical Trial.
Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers.
Schmitt-Hoffmann A, Roos B, Maares J, Heep M, Spickerman J, Weidekamm E, Brown T, Roehrle M. Schmitt-Hoffmann A, et al. Among authors: roos b. Antimicrob Agents Chemother. 2006 Jan;50(1):286-93. doi: 10.1128/AAC.50.1.286-293.2006. Antimicrob Agents Chemother. 2006. PMID: 16377699 Free PMC article. Clinical Trial.
Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers.
Schmitt-Hoffmann A, Roos B, Heep M, Schleimer M, Weidekamm E, Brown T, Roehrle M, Beglinger C. Schmitt-Hoffmann A, et al. Among authors: roos b. Antimicrob Agents Chemother. 2006 Jan;50(1):279-85. doi: 10.1128/AAC.50.1.279-285.2006. Antimicrob Agents Chemother. 2006. PMID: 16377698 Free PMC article. Clinical Trial.
679 results